<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(22)</volume><submitter>Correa-Leon YP</submitter><pubmed_abstract>The classification of carbapenemases can help guide therapy. The present study evaluated the performance of the CPO detection test, included in the BD Phoenix&lt;sup>™&lt;/sup> NMIC-501 panel for the detection and classification of carbapenemases on the representative molecularly characterized strains collection from Mexico. Carbapenem non-susceptible isolates collected in Mexico were included. The clinical isolates (&lt;i>n&lt;/i> = 484) comprised &lt;i>Klebsiella pneumoniae&lt;/i> (&lt;i>n&lt;/i> = 154), &lt;i>Escherichia coli&lt;/i> (&lt;i>n&lt;/i> = 150), and &lt;i>P. aeruginosa&lt;/i> (&lt;i>n&lt;/i> = 180). BD Phoenix CPO NMIC-504 and NMIC-501 panels were used for the identification of species, antimicrobial susceptibility tests, and detection of CPOs. For the detection of carbapenemase-encoding genes, &lt;i>E. coli&lt;/i> and &lt;i>K. pne</pubmed_abstract><journal>Diagnostics (Basel, Switzerland)</journal><pagination>3417</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10670751</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in &lt;i>Escherichia coli, Klebsiella pneumoniae&lt;/i> and &lt;i>Pseudomonas aeruginosa&lt;/i>.</pubmed_title><pmcid>PMC10670751</pmcid><pubmed_authors>Monroy-Colin VA</pubmed_authors><pubmed_authors>Padilla-Ibarra C</pubmed_authors><pubmed_authors>Quevedo-Ramos MA</pubmed_authors><pubmed_authors>Rodriguez-Noriega E</pubmed_authors><pubmed_authors>Lopez-Jacome LE</pubmed_authors><pubmed_authors>Martinez-Guerra BA</pubmed_authors><pubmed_authors>Mena-Ramirez JP</pubmed_authors><pubmed_authors>Feliciano-Guzman JM</pubmed_authors><pubmed_authors>Velazquez-Acosta MDC</pubmed_authors><pubmed_authors>Mireles-Davalos CD</pubmed_authors><pubmed_authors>Hernandez-Duran M</pubmed_authors><pubmed_authors>Lopez-Gutierrez E</pubmed_authors><pubmed_authors>Correa-Leon YP</pubmed_authors><pubmed_authors>Perez-Hernandez JM</pubmed_authors><pubmed_authors>Garza-Gonzalez E</pubmed_authors><pubmed_authors>Perez-Vicelis T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in &lt;i>Escherichia coli, Klebsiella pneumoniae&lt;/i> and &lt;i>Pseudomonas aeruginosa&lt;/i>.</name><description>The classification of carbapenemases can help guide therapy. The present study evaluated the performance of the CPO detection test, included in the BD Phoenix&lt;sup>™&lt;/sup> NMIC-501 panel for the detection and classification of carbapenemases on the representative molecularly characterized strains collection from Mexico. Carbapenem non-susceptible isolates collected in Mexico were included. The clinical isolates (&lt;i>n&lt;/i> = 484) comprised &lt;i>Klebsiella pneumoniae&lt;/i> (&lt;i>n&lt;/i> = 154), &lt;i>Escherichia coli&lt;/i> (&lt;i>n&lt;/i> = 150), and &lt;i>P. aeruginosa&lt;/i> (&lt;i>n&lt;/i> = 180). BD Phoenix CPO NMIC-504 and NMIC-501 panels were used for the identification of species, antimicrobial susceptibility tests, and detection of CPOs. For the detection of carbapenemase-encoding genes, &lt;i>E. coli&lt;/i> and &lt;i>K. pne</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-22T08:08:45.727Z</modification><creation>2025-04-05T22:26:13.771Z</creation></dates><accession>S-EPMC10670751</accession><cross_references><pubmed>37998553</pubmed><doi>10.3390/diagnostics13223417</doi></cross_references></HashMap>